Literature DB >> 6927555

Dementia in Parkinson disease: a neuropsychological analysis.

F J Pirozzolo, E C Hansch, J A Mortimer, D D Webster, M A Kuskowski.   

Abstract

An extensive set of neuropsychological measures was administered to 60 Parkinson's disease patients and age-, sex-, and education-matched controls in order to investigate the nature and prevalence of the cognitive deficit in the disease. Parkinsonian patients performed significantly poorer on all measures with the exception of tests for apraxia and object recognition, and on a test of vocabulary knowledge. Discriminant analysis of the test data revealed that over 93% of patients are impaired relative to matched controls, but that assigning a prevalence rate for dementia in the disease may be difficult due to the continuous distribution of cognitive deficits.

Entities:  

Mesh:

Year:  1982        PMID: 6927555     DOI: 10.1016/0278-2626(82)90007-0

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  31 in total

1.  Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

Authors:  I Litvan; E Mohr; J Williams; C Gomez; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 2.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

3.  Cognitive improvement during Tolcapone treatment in Parkinson's disease.

Authors:  M Gasparini; E Fabrizio; V Bonifati; G Meco
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.

Authors:  Daniel S Brown; Ira H Bernstein; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Mustafa Husain; Laura H Lacritz
Journal:  Int J Geriatr Psychiatry       Date:  2015-07-14       Impact factor: 3.485

5.  Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Tom Ten Have; Amy Colcher; Stacy S Horn; Paul J Moberg; Jayne R Wilkinson; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Journal:  J Am Geriatr Soc       Date:  2008-12-10       Impact factor: 5.562

6.  Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.

Authors:  Y Abe; T Kachi; T Kato; Y Arahata; T Yamada; Y Washimi; K Iwai; K Ito; N Yanagisawa; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

7.  Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

Authors:  B Pillon; B Dubois; G Cusimano; A M Bonnet; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

8.  Associations between cognitive and gait performance during single- and dual-task walking in people with Parkinson disease.

Authors:  Elizabeth L Stegemöller; Jonathan P Wilson; Audrey Hazamy; Mack C Shelley; Michael S Okun; Lori J P Altmann; Chris J Hass
Journal:  Phys Ther       Date:  2014-02-20

9.  The relationship between visuospatial ability and perceptual motor function in Parkinson's disease.

Authors:  M Richards; L J Cote; Y Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

10.  Reduced visuospatial performance in children with the D2 dopamine receptor A1 allele.

Authors:  S M Berman; E P Noble
Journal:  Behav Genet       Date:  1995-01       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.